217 Evaluating biomarkers of JTX-8064 (anti-LILRB2/ILT4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical development

Ítems similars

• LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation
  per: Muchaala Yeboah, et al.
  Publicat: (2020-09-01)
• Analysis of the Expression and Function of Immunoglobulin-Like Transcript 4 (ILT4, LILRB2) in Dendritic Cells from Patients with Systemic Lupus Erythematosus
  per: Paola del Carmen Guerra-de Blas, et al.
  Publicat: (2016-01-01)
• Impact of the NK Cell Receptor LIR-1 (ILT-2/CD85j/LILRB1) on Cytotoxicity against Multiple Myeloma
  per: Silke Heidenreich, et al.
  Publicat: (2012-01-01)
• 217 Evaluating biomarkers of JTX-8064 (anti-LILRB2/ILT4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical development
  per: Edward Stack, et al.
  Publicat: (2020-11-01)
• Unlocking the promise of innate biology through the HLA-G/ILT2/ILT4 pathway
  per: Courtney Beers, et al.
  Publicat: (2026-02-01)